Trial intelligence / Profile preview

Number of Doses and Time to Onset of Pain Relief Using the IONSYS System

2008-002653-21Phase 3Terminated

Sponsor
Janssen Pharmaceutical
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of fentanyl iontophoretic transdermal system in postoperative pain and pain, sponsored by Janssen Pharmaceutical. Started Jun 2008; status: terminated.

02

Drugs

fentanyl iontophoretic transdermal system
03

Conditions

postoperative painpain

Beyond the preview

Go deeper on 2008-002653-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002653-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call